Josie Hayes
0000-0001-6402-6320
Publication & Citation Trends
Publications
0 total
ARHGAP12 and ARHGAP29 exert distinct regulatory effects on switching between two cell morphological states through GSK-3 activity. OA
Cited by 0
Semantic Scholar
1226 CD24 gene amplification associates with poor survival outcomes across cancer indications
Cited by 0
Semantic Scholar
Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects OA
Cited by 132
Semantic Scholar
The bi-steric mTORC1-selective inhibitor RMC-5552 in tumors with activation of mTOR signaling: Preclinical activity in combination with RAS(ON) inhibitors in RAS-addicted tumors, and initial clinical findings from a single agent phase 1/1b study.
Cited by 5
Semantic Scholar
Abstract 449: Machine learning models identify histological features that can predict KEAP1 mutations in lung adenocarcinoma
Cited by 0
Semantic Scholar
Abstract LB001: Anti-tumor activity and tolerability of the SHP2 inhibitor RMC-4630 as a single agent in patients with RAS-addicted solid cancers
Cited by 10
Semantic Scholar
Identification of Cancer-Associated Fibroblasts in Glioblastoma and Defining Their Pro-tumoral Effects OA
Cited by 9
Semantic Scholar
Abstract LB050: Modulation of innate and adaptive immunity in blood and tumor of patients receiving the SHP2 inhibitor RMC-4630
Cited by 2
Semantic Scholar
Research Topics
MicroRNA in disease regulation
(34)
Circular RNAs in diseases
(23)
RNA modifications and cancer
(19)
Glioma Diagnosis and Treatment
(15)
Cancer-related molecular mechanisms research
(10)
Affiliations
Brigham and Women's Hospital
Centre National de la Recherche Scientifique
University of Leeds
Harvard University
Inserm